XML 18 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 28, 2024
Revenues:    
Revenues other than cost reimbursements $ 138,909 $ 129,369
Cost reimbursements 9,857 9,178
Total revenues 148,766 138,547
Costs and expenses:    
Advertising and marketing 5,244 5,301
Administrative 24,716 21,402
Depreciation and amortization 17,838 16,015
Rent 6,217 6,347
Property taxes 4,409 3,931
Other operating expenses 10,606 9,870
(Gain) loss on disposition of property, equipment and other assets (1,365) 23
Reimbursed costs 9,857 9,178
Total costs and expenses 169,178 155,212
Operating loss (20,412) (16,665)
Other income (expense):    
Investment income 74 692
Interest expense (2,822) (2,534)
Other income (expense) (444) (341)
Equity losses from unconsolidated joint ventures (570) (387)
Nonoperating income (expense), total (3,762) (2,570)
Loss before income taxes (24,174) (19,235)
Income tax benefit (7,358) (7,369)
Net loss $ (16,816) $ (11,866)
Common Stock    
Net loss per share - basic:    
Net loss per share - basic (in dollars per share) $ (0.54) $ (0.38)
Net loss per share - diluted:    
Net loss per share - diluted (in dollars per share) (0.54) (0.38)
Class B Common Stock    
Net loss per share - basic:    
Net loss per share - basic (in dollars per share) (0.50) (0.34)
Net loss per share - diluted:    
Net loss per share - diluted (in dollars per share) $ (0.50) $ (0.34)
Theatre admissions    
Revenues:    
Revenues $ 40,931 $ 40,596
Rooms    
Revenues:    
Revenues 19,275 18,213
Costs and expenses:    
Costs 9,906 9,411
Theatre concessions    
Revenues:    
Revenues 38,000 34,695
Costs and expenses:    
Costs 17,451 14,886
Food and beverage    
Revenues:    
Revenues 17,829 16,163
Costs and expenses:    
Costs 14,629 13,863
Other revenues    
Revenues:    
Revenues 22,874 19,702
Theatre operations    
Costs and expenses:    
Costs $ 49,670 $ 44,985